TY  - GEN
AU  - Zhu,Chang-Qi
AU  - da Cunha Santos,Gilda
AU  - Ding,Keyue
AU  - Sakurada,Akira
AU  - Cutz,Jean-Claude
AU  - Liu,Ni
AU  - Zhang,Tong
AU  - Marrano,Paula
AU  - Whitehead,Marlo
AU  - Squire,Jeremy A
AU  - Kamel-Reid,Suzanne
AU  - Seymour,Lesley
AU  - Shepherd,Frances A
AU  - Tsao,Ming-Sound
TI  - Role of KRAS and EGFR as biomarkers of response to erlotinib in National Cancer Institute of Canada Clinical Trials Group Study BR.21
SN  - 1527-7755
PY  - 2008///0922
KW  - Antineoplastic Agents
KW  - therapeutic use
KW  - Canada
KW  - Carcinoma, Non-Small-Cell Lung
KW  - drug therapy
KW  - Erlotinib Hydrochloride
KW  - Female
KW  - Genes, erbB-1
KW  - genetics
KW  - Genotype
KW  - Humans
KW  - In Situ Hybridization, Fluorescence
KW  - Lung Neoplasms
KW  - Male
KW  - Middle Aged
KW  - Mutation
KW  - Predictive Value of Tests
KW  - Proto-Oncogene Proteins
KW  - Proto-Oncogene Proteins p21(ras)
KW  - Quinazolines
KW  - Survival Analysis
KW  - ras Proteins
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1200/JCO.2007.14.8924
ER  -